Immune Responses following Stereotactic Body Radiotherapy for Stage I Primary Lung Cancer

Table 1

Patient characteristics.

	Group I	Group II
	(𝑛=36)	(𝑛=26)
Sex
Male	25	17
Female	11	9
Age (years)	61–90	64–89
	(median: 80)	(median: 81)
Dose/fractionation
40–60 Gy/4 fr	29	20
60–70 Gy/10 fr	7	6